Minerva Neurosciences Files Definitive Proxy Statement

Ticker: NERV · Form: DEF 14A · Filed: Oct 22, 2024 · CIK: 1598646

Sentiment: neutral

Topics: proxy-statement, annual-meeting, governance

TL;DR

Minerva Neurosciences DEF 14A filed. Annual meeting Dec 5. Vote your shares!

AI Summary

Minerva Neurosciences, Inc. filed its definitive proxy statement (DEF 14A) on October 22, 2024, for its annual meeting of stockholders. The filing provides details regarding the meeting, which is scheduled for December 5, 2024, and includes information relevant to shareholder voting and corporate governance.

Why It Matters

This filing is crucial for shareholders as it outlines the agenda for the annual meeting, proposals to be voted on, and information about the company's leadership, enabling informed participation in corporate decisions.

Risk Assessment

Risk Level: low — This is a routine annual filing providing information to shareholders and does not contain new material financial or operational news.

Key Numbers

Key Players & Entities

FAQ

What is the purpose of a DEF 14A filing?

A DEF 14A filing, or definitive proxy statement, is used by companies to solicit proxy votes from shareholders for an upcoming meeting, providing detailed information about the matters to be voted upon.

When is the Minerva Neurosciences, Inc. annual meeting scheduled?

The annual meeting of stockholders for Minerva Neurosciences, Inc. is scheduled for December 5, 2024.

What is the filing date of this proxy statement?

This definitive proxy statement was filed on October 22, 2024.

Where is Minerva Neurosciences, Inc. headquartered?

Minerva Neurosciences, Inc. is located at 1601 Trapelo Road, Suite 286, Waltham, MA 02451.

What is the SIC code for Minerva Neurosciences, Inc.?

The Standard Industrial Classification (SIC) code for Minerva Neurosciences, Inc. is 2834, which corresponds to Pharmaceutical Preparations.

Filing Stats: 4,887 words · 20 min read · ~16 pages · Grade level 11.9 · Accepted 2024-10-22 07:06:56

Filing Documents

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 23

EXECUTIVE COMPENSATION

EXECUTIVE COMPENSATION 25 Summary Compensation Table 25 Outstanding Equity Awards at Fiscal Year-End 25 Arrangements with Our Executive Officers 26 DIRECTOR COMPENSATION 33 TRANSACTIONS WITH RELATED PERSONS RELATED PERSON TRANSACTIONS POLICY AND PROCEDURES 35 Certain Relationships and Related Person Transactions 35 EQUITY COMPENSATION PLAN INFORMATION 38 HOUSEHOLDING OF PROXY MATERIALS 38 OTHER MATTERS 39 i Table of Contents MINERVA NEUROSCIENCES, INC. 1500 District Avenue Burlington, MA 01803 PROXY STATEMENT FOR THE 2024 ANNUAL MEETING OF STOCKHOLDERS To Be Held on December 5, 2024 QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING Why did I receive a notice regarding the availability of proxy materials on the Internet? Pursuant to rules adopted by the Securities and Exchange Commission, or the SEC, we have elected to provide access to our proxy materials over the Internet. Accordingly, we have sent you a Notice of Internet Availability of Proxy Materials, or the Notice, because the Board of Directors of the Company, or the Board, is soliciting your proxy to vote at the 2024 Annual Meeting of Stockholders, or the Annual Meeting, including at any adjournments or postponements of the Annual Meeting. The Notice contains instructions about how to access our proxy materials online and vote online. All stockholders will have the ability to access the proxy materials on the website referred to in the Notice or request to receive a printed set of the proxy materials. Instructions on how to access the proxy materials over the internet or to request a printed copy may be found in the Notice. We intend to mail the Notice on or about October 22, 2024 to all stockholders of record entitled to vote at the Annual Meeting. Why are you holding a virtual Annual Meeting? We believe that hosting a virtual meeting is in the best interest of the Company and its stockholders and enables increased stockholder atten

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on Read The Filing